Blinklab Limited (AU:BB1) has released an update.
BlinkLab Limited, a trailblazer in digital healthcare, will showcase its AI-driven smartphone diagnostic tests for neurological disorders at TechKnow Invest, Australia’s premier tech investment event. The company’s revolutionary products, including an early-stage autism diagnostic tool, highlight its commitment to leveraging advanced technology for timely interventions. Investors and shareholders can join the presentation in Sydney and Melbourne on July 30 and 31, 2024, either in person or via live stream.
For further insights into AU:BB1 stock, check out TipRanks’ Stock Analysis page.
